These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16637928)

  • 41. Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
    Siffrin V; Vogt J; Radbruch H; Nitsch R; Zipp F
    Trends Neurosci; 2010 Apr; 33(4):202-10. PubMed ID: 20153532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospects of cell therapy for disorders of myelin.
    Ben-Hur T; Goldman SA
    Ann N Y Acad Sci; 2008 Oct; 1142():218-49. PubMed ID: 18990129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Axonal damage in multiple sclerosis.
    Haines JD; Inglese M; Casaccia P
    Mt Sinai J Med; 2011; 78(2):231-43. PubMed ID: 21425267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remyelination in multiple sclerosis: a challenge for therapy. The 1996 European Charcot Foundation Lecture.
    Compston A
    Mult Scler; 1997 Apr; 3(2):51-70. PubMed ID: 9291155
    [No Abstract]   [Full Text] [Related]  

  • 45. No quiet surrender: molecular guardians in multiple sclerosis brain.
    Steinman L
    J Clin Invest; 2015 Apr; 125(4):1371-8. PubMed ID: 25831441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiopathology of symptoms and signs in multiple sclerosis.
    Sá MJ
    Arq Neuropsiquiatr; 2012 Sep; 70(9):733-40. PubMed ID: 22990733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple sclerosis.
    Compston A; Coles A
    Lancet; 2008 Oct; 372(9648):1502-17. PubMed ID: 18970977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress in determining the causes and treatment of multiple sclerosis.
    Noseworthy JH
    Nature; 1999 Jun; 399(6738 Suppl):A40-7. PubMed ID: 10392579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis.
    Rodriguez M
    Brain; 2003 Apr; 126(Pt 4):751-2. PubMed ID: 12615635
    [No Abstract]   [Full Text] [Related]  

  • 50. Scientists probe strategies to repair neuron damage in multiple sclerosis.
    Kuehn BM
    JAMA; 2011 Mar; 305(9):871-2, 874. PubMed ID: 21364130
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunotherapeutic approaches in MS: update on pathophysiology and emerging agents or strategies 2006.
    Kleinschnitz C; Meuth SG; Kieseier BC; Wiendl H
    Endocr Metab Immune Disord Drug Targets; 2007 Mar; 7(1):35-63. PubMed ID: 17346203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple sclerosis with evidence of remyelination.
    Anzil AP
    J Neuropathol Exp Neurol; 1990 Mar; 49(2):193-4. PubMed ID: 2307985
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuroplasticity and functional recovery in multiple sclerosis.
    Tomassini V; Matthews PM; Thompson AJ; Fuglø D; Geurts JJ; Johansen-Berg H; Jones DK; Rocca MA; Wise RG; Barkhof F; Palace J
    Nat Rev Neurol; 2012 Nov; 8(11):635-46. PubMed ID: 22986429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut response. Therapy with ingested immunomodulatory proteins.
    Brod SA
    Arch Neurol; 1997 Oct; 54(10):1300-2. PubMed ID: 9341578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remyelination in Multiple Sclerosis. Proceedings of the European Charcot Foundation Symposium. Vienna, Austria, 4-6 July 1996.
    Mult Scler; 1997 Apr; 3(2):51-169. PubMed ID: 9324422
    [No Abstract]   [Full Text] [Related]  

  • 56. Multiple sclerosis in its European matrix: some aspects of history, mechanisms and treatment.
    McDonald I
    Can J Neurol Sci; 2004 Feb; 31(1):37-47. PubMed ID: 15038469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Limiting and repairing the damage in multiple sclerosis.
    Compston A
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):945-8. PubMed ID: 1800662
    [No Abstract]   [Full Text] [Related]  

  • 58. Multiple sclerosis 2001.
    Poser CM; Brinar VV
    Clin Neurol Neurosurg; 2002 Jul; 104(3):165-7. PubMed ID: 12127648
    [No Abstract]   [Full Text] [Related]  

  • 59. Changing Paradigms and Unmet Needs in Multiple Sclerosis: The Role of Clinical Neurophysiology.
    Skeen MB
    J Clin Neurophysiol; 2021 May; 38(3):162-165. PubMed ID: 33958565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Future prospects for the management of multiple sclerosis.
    Compston A
    Ann Neurol; 1994; 36 Suppl():S146-50. PubMed ID: 8017879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.